DR.ESLEE SUN MATTE- octinoxate liquid 
Ajou Medics Co., Ltd

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Drug Facts

active ingredient: ethylhexyl methoxycinnamate

inactive ingredient: Butylene Glycol, 4-Methylbenzylidene Camphor, Titanium Dioxide, Cetyl Alcohol, Octocrylene, Hydrogenated Polydecene, Polysorbate 80, Cyclomethicone, Stearic Acid, Glyceryl Stearate, PEG-100 Stearate, Sorbitan Stearate, Polyhydroxystearic Acid, Aluminum Hydroxide, Triethanolamine, Carbomer, Xanthan Gum, Poncirus Trifoliata Fruit Extract, Aloe Barbadensis Leaf Juice, Sodium Hyaluronate, Biosaccharide Gum-1, Tocopheryl Acetate, Disodium EDTA, Salicylic Acid, Farnesyl Acetate, Farnesol, Panthenyl, Triacetate, Hydrolyzed Algin, Zinc Sulfate, Phenoxyethanol, Methylparaben, Propylparaben, Butylparaben

helps protect from UV-Rays

keep out of reach of the children

■ Apply Proper Amount of the cream on skin before sun exposure

■ For external use only. Avoid contact with eyes.
■ Avoid contact with eyes.
■ Do not swallow. If swallowed, get medical help.
■ Keep out of reach of children.
■ Stop use and ask doctor if rash and irritation develops.

Reapply Frequently, every 2 hours for best result

package label
DR.ESLEE SUN MATTE 
octinoxate liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:76340-3001
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE7.5 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
ENZACAMENE (UNII: 8I3XWY40L9)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
C12-16 ALCOHOLS (UNII: S4827SZE3L)  
OCTOCRYLENE (UNII: 5A68WGF6WM)  
HYDROGENATED POLYDECENE (550 MW) (UNII: U333RI6EB7)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
CYCLOMETHICONE (UNII: NMQ347994Z)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
PEG-100 STEARATE (UNII: YD01N1999R)  
SORBITAN MONOSTEARATE (UNII: NVZ4I0H58X)  
POLYHYDROXYSTEARIC ACID (2300 MW) (UNII: YXH47AOU0F)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
TROLAMINE (UNII: 9O3K93S3TK)  
XANTHAN GUM (UNII: TTV12P4NEE)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
BIOSACCHARIDE GUM-1 (UNII: BB4PU4V09H)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
SALICYLIC ACID (UNII: O414PZ4LPZ)  
FARNESOL (UNII: EB41QIU6JL)  
ZINC SULFATE (UNII: 89DS0H96TB)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
BUTYLPARABEN (UNII: 3QPI1U3FV8)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:76340-3001-160 g in 1 TUBE; Type 0: Not a Combination Product01/01/201604/18/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other08/10/201104/18/2022
Labeler - Ajou Medics Co., Ltd (688796473)
Registrant - Ajou Medics Co., Ltd (688796473)
Establishment
NameAddressID/FEIBusiness Operations
Ajou Medics Co., Ltd688796473manufacture(76340-3001)

Revised: 4/2022
 
Ajou Medics Co., Ltd